Interestingly, another study was performed using a custom library containing sgRNAs disrupting MYC binding sites in order to identify MYC-dependent vulnerabilities involved in the development of CML [64]. This evidence concerns the gene MYC and chronic myelogenous leukemia, BCR-ABL1 positive.